Literature DB >> 10552333

Sclerotherapy with a ligation of incompetent veins for a stasis ulcer due to varix cruris: minimal invasive therapy for varix cruris.

Y Takeda1, T Agui, K Tanaka, M Okuzawa, N Tanigawa.   

Abstract

A retrospective analysis was performed on 11 patients (mean age 50 years), consisting of 8 men and 3 women, with a stasis ulcer due to varix cruris who underwent sclerotherapy with a ligation of incompetent veins on an outpatient basis. The follow-up ranged from 26 to 76 months (mean 53 months). The ulcers healed in 14 to 128 days (mean 41 days) after this procedure except in 1 patient. Three patients healed within 1 month and 7 others within 2 months. Only 1 patient needed over 2 months to heal. A recurrence of the ulcer was observed in 1 case 59 days after healing, and incompetent perforating veins were newly identified. This patient required an additional endoscopic subfascial division of the perforating veins and is now in the process of healing. No deterioration of the ulcer was observed. Thrombophlebitis and faintness were observed in 1 patient each. Neither pulmonary embolism nor deep venous thrombosis was observed. In conclusion, sclerotherapy with a ligation of any incompetent veins was found to be a safe and effective treatment for a stasis ulcer due to varix cruris; however, long-term observation will be required to confirm the effectiveness of this procedure. To successfully use combination therapy with less or minimally invasive procedures, a precise diagnosis of vein incompetency is crucial.

Entities:  

Mesh:

Year:  1999        PMID: 10552333     DOI: 10.1007/BF02482264

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

1.  Subfascial endoscopic perforator ligation: an analysis of early clinical outcomes and cost.

Authors:  M D Iafrati; H J Welch; T F O'Donnell
Journal:  J Vasc Surg       Date:  1997-06       Impact factor: 4.268

2.  Hemodynamic and clinical improvement after superficial vein ablation in primary combined venous insufficiency with ulceration.

Authors:  F T Padberg; P J Pappas; C T Araki; T L Back; R W Hobson
Journal:  J Vasc Surg       Date:  1996-11       Impact factor: 4.268

3.  Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry.

Authors:  P Gloviczki; J J Bergan; S S Menawat; R W Hobson; R L Kistner; P F Lawrence; A Lumsden; T F O'Donnell; R G DePalma; J Murray; J P Pigott; H Schanzer; E Ascer; P Kalman; K D Calligaro; J L Ballard; R A Cambria; R Y Rhee; B G Rubin; D M Ilstrup; W S Harmsen; L G Canton
Journal:  J Vasc Surg       Date:  1997-01       Impact factor: 4.268

4.  Surgery and sclerotherapy in the treatment of varicose veins. A random trial.

Authors:  J T Hobbs
Journal:  Arch Surg       Date:  1974-12

5.  Subfascial endoscopic perforator surgery is associated with significantly less morbidity and shorter hospital stay than open operation (Linton's procedure)

Authors:  W P Stuart; D J Adam; A W Bradbury; C V Ruckley
Journal:  Br J Surg       Date:  1997-10       Impact factor: 6.939

6.  Early benefits of subfascial endoscopic perforator surgery (SEPS) in healing venous ulcers.

Authors:  S R Sparks; J L Ballard; J J Bergan; J D Killeen
Journal:  Ann Vasc Surg       Date:  1997-07       Impact factor: 1.466

7.  Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.

Authors:  J M Porter; G L Moneta
Journal:  J Vasc Surg       Date:  1995-04       Impact factor: 4.268

8.  Subfascial endoscopic perforator vein surgery: a preliminary report.

Authors:  J J Bergan; J Murray; K Greason
Journal:  Ann Vasc Surg       Date:  1996-05       Impact factor: 1.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.